AYTU BioScience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AYTU BioScience, Inc. on March 25, 2020, regarding an event that occurred on March 24, 2020. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "AYTU".
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report is strictly a notification regarding stock listing status.
Material Changes
The primary material event reported is the resolution of a prior delisting notice. On March 24, 2020, the company received notification from Nasdaq Regulation that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), known as the Bid Price Rule. This compliance was achieved because the company's stock price traded above $1.00 for at least 10 consecutive business days following a previous notice issued on February 19, 2020.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It does not disclose new risks or contingencies beyond the resolution of the specific listing deficiency regarding the minimum bid price.
Key Facts for Investor Verification
- Confirm the current trading status of AYTU stock on The NASDAQ Stock Market LLC.
- Verify that the stock price has maintained the $1.00 threshold for the required consecutive business days to ensure continued compliance.
- Note that this filing resolves the delisting risk associated with the February 19, 2020 notice.